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Summary 
Recent  experiments have strongly suggested that the process of Somatic mutation is linked to 
transcription initiation.  It was postulated that a mutator factor~ loads onto the lLNA polymerase 
and, during elongation,  causes transcriptional arrest that activates DNA repair, thus occasionally 
causing errors in the DNA  sequence.  We report the analysis of the role of one of the known 
DNA  repair  systems,  nucleotide  excision  repair  (NELL),  in  somatic  mutation.  Epstein-Barr- 
virus-transformed B  cells from patients with defects in NELL (XP-B, XP-D, XP-V, and CS-A) 
were studied.  Their heavy and light chain genes show a high frequency of point mutations in 
the  variable  (V),  but  not in the  constant  (C) regions.  This suggests that these B  cells can un- 
dergo somatic hypermutation despite significant defects in NEk.  Thus, it is doubtful that NELL 
is an essential part of the mechanism of somatic hypermutation  of Ig genes. As an aside, NElL 
seems also not involved in Ig gene switch recombination. 
As~ 
gh level of Ig variable  (V) 1 region  diversity arises in 
ature  B  cells  during  somatic  hypermutation  of the 
expressed Ig genes  (1).  The mutations  are restricted  to the 
V  region  and its immediate  5'  and 3'  flanks,  extending  to 
about 1.5 kb from the start of the V  gene, whereas the pro- 
moter-upstream region and the constant  (C) region gener- 
ally are not mutated (2-4). 
The  molecular  basis  of somatic  hypermutation  is  not 
known.. Several studies  have  suggested  that  transcriptional 
control elements may be required for somatic mutation  (3, 
5,  6).  To determine whether  transcription  was directly in- 
vovled, we created a light chain transgene whose transcrip- 
tional promoter was duplicated and placed upstream of the 
C  region (7). B  cells of these mice showed similar levels of 
somatic  point  mutations  in  both  the  V-joining  (J)  region 
and the C  region, but not in the intron between these. The 
data strongly  suggested  that  somatic  mutation  is linked  to 
transcription initiation.  To explain the link to transcription, 
we have proposed a model of transcription-coupled  DNA 
repair  (7).  In this  model,  a mutator factor is bound  to the 
RNA  polymerase  during  initiation  and  remains  associated 
with the polymerase during elongation.  It is postulated that 
the  mutator  factor would  cause  prolonged  stalling  of the 
polymerase  at  some  point  along  the  first  1.5  kb  of tran- 
scribed  DNA.  This  would  call into  action  a  DNA  repair 
complex  that  would  cause  the  excision  of the  DNA  se- 
quence  in  which  the  stalled  complex  is located.  Replica- 
tion of the  excised segment of DNA would result in occa- 
sional errors, which would eventually be preserved as point 
mutations. 
There  are a number of known  repair systems, as well as 
possibly novel ones,  that may be involved.  We report the 
analysis of the role of certain proteins that are known to be 
required  for nucleotide  excision repair  (NELL)  (8).  The Ig 
genes expressed in EBV transformed B  cell lines from four 
patients were the subjects of the study. 
1Abbreviations used in this  paper: C, constant; CPD, cyclobutane pyrimidine 
dimers; CS, Cockayne syndrome; J, joining;  NER, nucleotide excision 
repair; RACE, rapid amplification of cDNA ends; V, variable; XP, xero- 
derma pigmentogum. 
Materials and Methods 
EBV-transformed Lymphocytes.  All cell cultures were from Na- 
tional Institute of General Medical Sciences Human Genetic Mu- 
tant  Cell  Repository,  Coriell  Institute  for  Medical  Research, 
(Camden, NJ). Three EBV-transformed lymphocyte cultures un- 
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XP-B  -/-:  31-yr-old female; 
* (GM02252A) 
XP-D  -/-:  5-yr-old male; 
(GM03249) 
XP-V  -/-:  9-yr-old female; 
(GM10902 
CS-A  -/-:  13-yr-old male; 
(GM01857A) 
Cockayne symptoms: UV sensitivity; mutation in RNA splice site ofXP-B gene 
*(3' --) 5' DNA helicase; component of transcription factor TFIIH 
Cockayne symptoms; neurological symptoms; UV sensitivity 
(5' --> 3' DNA helicase; component of transcription factor TFIIH) 
photosensitivity; Cockayne symptoms: microcephaly; growth retardation; ataxia 
(function unknown; involved in NER and postreplication DNA repair) 
Cockayne syndrome; low UV recovery 
(repair of transcriptionally active DNA; interacts with TFIIH) 
*  Cell repository catalog number; :~Putative  function of the gene product. 
der analysis  were  from xeroderma pigmentosum  (XP)  patients: 
XP-B, XP-D, XP-V, and one from a Cockayne syndrome (CS- 
A) patient (Table 1). The cells were grown in RPMI-1640 me- 
dium with 15% FCS. From each sample, genomic DNA and total 
RNA were isolated. 
Primers.  (For ease of reading, the primers are written in trip- 
lets that however,  are unrelated to coding triplets). CgR.T,  5'- 
TCT TGT CCA CCT TGG TGT TGC T-3'; Cmb (reference 
9; 5'-GGG GAA TTC TCA CAG GAG ACG AGG GGG AA- 
3'; Cgb  (9)  5'-ATC AGT CGA CAA GAC CGA TGG GCC 
CTT  GGT GGA-Y; CmRT  5'-GCC AGC TGT  GTC  GGA 
CAT GAC-3'; VH4 (10), 5'-ACT AGT CGA CCC TGT CCC 
TCA CCT  GC(A/G)CTG TC-3';  CkRT  (11),  5'-CAT CAG 
ATG GCG GGA AGA T-3'; HUVK1FOR (12), 5'-GGT GCA 
GCC ACA GTA CGT TAG ATC TCC  A-3'; VH6  (13),  5'- 
GTA AAG CTT CAG CAG TCA GGT-3'; V26-FW1 (14), 5'- 
CGC CGG ATC CTG TGA GGT GCA GCT GT-3'; hc3pall 
(15),  5'-GAG AGA CCC  CTC  CCC  TGG GA-3'; hclam re- 
verse (15), 5'-AGT GTG GCC TTG TTG GCT TG-3'. 
Cloning of Heavy Chain cDNAs.  Expressed  IgH  chain  genes 
were first cloned by using the VH family-specific primers listed 
above. First-strand cDNA synthesis was carried out with either 
the CgRT primer, which anneals to the 3' end of human C'y1, 
C~/2, C~/3, and C"/4, or the CmRT primer, which anneals to the 
3' end of human Cp~. Then, a portion of the cDNA was used as 
template in the PCR step carried out with one of three family- 
specific primers, VH4,  VH6,  or V26-fw1,  as the 5' primer and 
one of the two constant region primers, CgRT or CmRT, as 3' 
primers.  High  fidelity DNA  polymerase  PFU  (Stratagene,  La 
Jolla, CA)  was used.  The  PCR  products were  cloned into  the 
BluescriptlI KS+ vector (Stratagene). Automated sequencing was 
carried out using T3 and T7 vector primers and a dye terminator 
method. 
Additional heavy chain clones were obtained by a rapid ampli- 
fication of cDNA ends  (RACE)  kit  (GibcoBKL, Gaithersburg, 
MD). Amplification of cDNA fragments was done as indicated in 
the manual of the RACE kit. Taq DNA polymerase was used for 
PCR because inosine incorporated in the anchor primer will not 
allow the use of PFU DNA polymerase, which has exonuclease 
activity. The PCR  product was cloned into the EcoRV site of 
BluescriptlI KS+  by the TA cloning method  (16).  Automated 
and manual (Sequenase kit from GIBCO BILL; T3 and T7 vector 
primers and anchor primer) DNA sequencing was done. 
Cloning of K and A Chain cDNAs.  Expressed VK  and  VX  se- 
quences were cloned by RACE. Primers used in the reverse tran- 
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scription (RT) step were hC3pall, specific for the 3' end of hu- 
man  Ch,  and  CkR.T,  specific for  human  CK.  Hclam  reverse 
primer used in amplification of Vk is complementary to a region 
highly homologous in all human k  C  regions, about 60 to 80 bp 
downstream  of the J-C  splice site.  The  HUVK1FOR  primer 
used to amplify Vk sequences is complementary to the 3' end of 
five human K light chain J segments and to the first 14 nucleotides 
of the human CK region. 
Alignment of cDNA Sequences to Genomic Sequences.  All  cDNA 
sequences were compared with germline reference sequences of 
V region genes to determine base changes due to somatic hyper- 
mutation.  The V~  sequences  (17)  were  retrieved from IMGT, 
the  ImMunoGeneTics  database  (http://imgt.cnusc.fr:8104)  and 
were aligned using the multiple sequence alignment tool Clustal 
W  (1.4) (18) with default parameters (gap open penalty =  10), on 
unix  station.  The  germline VH  sequences  are unpublished  (F. 
Matsuda, unpublished data). The germline VK sequences are from 
the EMBL/GenBank. 
Results 
Clonality of EBV-transformed Lymphocyte Cultures.  South- 
em blot analysis was carried out to determine the clonality 
of the lymphocyte cultures  (data not shown).  All four cell 
cultures  under  analysis  are  oligoclonal.  Specifically, there 
were two major rearranged JH-containing bands for CS-A, 
four major bands  for XP-V,  two  major bands  for XP-B, 
and four major bands for XP-D. This information led us to 
employ the  RACE  method  in  order to  done  out  all,  or 
most of the expressed Ig genes in addition to using a  con- 
ventional PCtL method with V  gene-family specific prim- 
ers.  Also,  RT-PCR  showed  that  the  XP-B  lymphocyte 
culture  contains no  detectable Iglx or IgK transcript.  The 
other three, XP-V,  XP-D,  and  CS-A, contained Ig~ and 
Ig',/, as well as Igh and IgK transcripts (data not shown). 
Cloning and Sequencing IgV Region Genes.  Fig.  1  shows 
various Ig clones obtained from each of the four cell lines 
and the region sequenced. We sequenced the D-J regions 
in the case  of heavy chain genes  and  the J  regions in  the 
case  of the  light  chain  genes  to  confirm  that  individual 
clones are not represented in duplicates. Clones XPD4 and 
XPD2-2,  for  example,  use  the  same  V  and J  genes,  but 
Nucleotide Excision Repairs Deficient B Cells Table 2.  Summary of Somatic Point Mutations in XP and CS-A Cell Lines 
Cell line  Clone  Mutations*  Total bp* 
Percentage 
of mutations 
R/S$ 
FR  CDR 
XPB  -lam2  15  305  4.9  1.3  2.5 
XPB  -gl  28  475  5.9  1.2  2.0 
Total XP-B  43  780  5.5  1.25  2.25 
XPD  -4  1  350  0.28 
XPD  2-2  0  348  0 
XPD  2-1  1  341  0.29  1.0 
XPD  2-g2~  17  463  3.7  2.5  7.0 
XPD  2-g4  14  474  2.9  4.0  3.5 
XPD  2-1am4  7  342  2.0  0.25  2.0 
XPD  2-1am2  5  318  1.6  0.25 
XPD  2-1am6  14  308  4.5  1.0  4.0 
XPD  2-k5  1  320  0.31  >  1.0 
Total XP-D  60  3264  1.8  1.4  4.1 
XPV  -3  4  337  1.2  >2.0  1.0 
XPV  -2  8  303  2.6  1.5  >3.0 
XPV  -1  10  337  3.0  2.0  2.0 
XPV  -ml  11  413  2.6  0.7  2.0 
XPV  -gl  27  340  7.9  6.0  3.5 
XPV  -lam4  1  306  0.33  <1.0 
XPV  -lam211  7  341  2.0  3.0  >2.0 
XPV  -k5  5  347  1.4  >  1.0  0.3 
XPV  -k7  4  331  1.2  >  1.0  >  1.0 
Total XP-V  77  3055  2.5  1.9  2.2 
CSA  -3  3  340  0.88  > 1.0 
CSA  -2  8  334  2.4  4.0  >2.0 
CSA  -m7  8  445  1.8  1.0  >4.0 
CSA  -m6  7  440  1.6  3.0  >2.0 
CSA  -g5  16  472  3.4  2.5  7.0 
CSA  -g4  18  475  3.8  3.0  8.0 
CSA  -lam4  6  329  1.8  0.7 
CSA  -lam2  0  326  0 
CSA  -k3JI  1  328  0.3  >1.0 
CSA  -k5  1  330  0.3  <  1.0 
CSA  -kl 1  I0  327  3.1  1.0  3.0 
Total CS-A  78  4146  1.8  2.0  3.9 
FR, framework region. 
*Only the base pairs sequenced in the V andJ regions are included here. 
SReplacement/silent mutations in the V region; changes by V(D)J joining are excluded. 
~Stop codon due to mutation. 
IIOut of frame: excluded from the total R/S (column 6, 7). 
415  Kim et al. have distinctly different N  regions and D  regions (data not 
shown). 
All Four Patients Show Evidence of Somatic Hypermutation of 
Their Heavy and La'ght Chain V Region Genes.  The  sequence 
of each cDNA clone was aligned to germline V  gene se- 
quences. The differences between the cDNA sequence and 
the sequence  of a gennline  gene that is the  closest match 
were considered as mutations as outlined in Fig.  1. Table 2 
shows that almost every sequence had mutations. The mu- 
tation frequency for individual clones ranges from 0-7.9% 
(Table 2).  It is clear that all four patients from whom these 
cells are derived are capable of undergoing somatic hyper- 
mutation  of Ig genes.  The  oldest patient,  XP-B,  had  the 
highest mutation frequency, as is normally expected (9). 
Discussion 
This study shows that patients with defects in NER can 
somatically mutate Ig genes. As an aside, they must also be 
capable  of Ig  gene  switch  recombination,  because  IgG 
mR.NAs were found in the B cells of all four patients. 
The Base Changes Seen in  This Study  Are Due to Somatic 
Hypermutation.  The base pair changes seen in the cDNA 
sequences outlined in Fig.  1 are comparable to those seen 
in other studies of somatic hypermutation in human.  They 
are  considerably  higher  than  the  IkT-PCR  error  rate  of 
10 -4 bp (19).  Although DNA repair in the cell cultures in 
this study is slightly compromised due to defects in compo- 
nents of NER, the mutation rate due to defective NER is 
at least five orders  of magnitude lower than the mutation 
rate found here (20,  21).  The fact that no mutations were 
found  in  the  constant  regions  in  this  study  also  supports 
this. It also seems unlikely that the changes are due to poly- 
morphism, because known polymorphism was  taken into 
consideration and excluded when tabulating the mutations. 
Furthermore, there were very few changes compared with 
germline  sequences  in  the  leader  region,  the  region  that 
normally undergoes a low frequency of mutation, but where 
polymorphism would be as high as in the V region. Finally, 
there are cases where two sequences from one patient have 
exactly the same D  and N  sequences,  suggesting that they 
arose from the  same precursor cell,  but where  the  V  re- 
gions  differ and  thus  apparently diverged  during  somatic 
mutation in different progeny cells. 
Therefore, the mutations are most likely due to the so- 
matic  hypermutation  process.  It  appears  that  the  XP-B, 
XP-D,  XP-V,  and  CS-A  gene products  are  not required 
for somatic mutation of Ig genes. 
It  is  possible  that  these  genes  involved  in  NER  may 
somewhat alter the quality of the somatic point mutations. 
While,  as is normal in somatic mutation,  transitions  were 
more frequent than transversions (Fig.l),  subtle changes in 
unselectable nucleotides  could not be determined.  Almost 
all  of the  mRNAs  were  in  an  open  translational  reading 
frame (Table 2)  and therefore likely selected for function. 
Selection  is further supported by the higher R/S  ratio in 
the CDRs than in the framework regions (Table 2). There- 
fore, an analysis  of strand bias and hotspots would not be 
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reliable. Such a study will now be carried out in mice that 
are mutant for certain NER genes. 
DNA Repair and Somatic Hypermutation.  DNA repair cou- 
pled to transcription in eukaryotic cells  was first proposed 
when  it  was  observed that  there  is  preferential  repair  of 
UV-induced cyclobutane pyrimidine dimers (CPD) in the 
transcribed  strand  of active  genes  relative  to  that  in  the 
nontranscribed strand  (22,  23).  In the model for transcrip- 
tion-coupled repair, the R.NA polymerase complex, when 
stalled at a DNA lesion, such as CPD, recruits a DNA re- 
pair complex, such as the NER machinery, through bind- 
ing to a transcription repair coupling factor (24,  25).  Hu- 
man genetic  disorders like xeroderma pigmentosum (XP) 
and Cockayne's syndrome (CS) are attributed to defects in 
various components of the  NER machinery  (26).  Several 
of the proteins involved in NER  also  play a role in tran- 
scription  (8,  27).  It  appears  that  patients  with  defective 
NER genes who are not only deficient in NER, but also in 
transcription,  exhibit  symptoms of Cockayne  disease  (re- 
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Figure  1.  Sequence alignments of heavy and light chain cDNAs from patients with XP-B, XP-D, XP-V and CS-A. On the top a general map of 
heavy and light chain genes is shown. The individual maps below show the approximate positions of nucleotide changes compared with germline V 
genes. Dotted lines represent unsequenced regions. As a control, "~300 nucleotides of the constant regions ofXPD-4, XPD2-1, XPD2-2, XPV-1, XPV-2, 
XPV-3, CSA-1, CSA-2, and CSA-3 were sequenced; no mutations were found. *These two clones have the same V and J, but different N  and D  se- 
quences. 
tarded growth, neurological abnormalities; reference 26).  This 
is presumably because fetal and early postnatal development 
is especially sensitive to subtle  defects in the  transcription 
function. All of the NER-defective B  cell lines chosen for 
this  study  were  from  patients  who  exhibited  Cockayne 
symptoms (Table  1),  because we were testing a model of 
transcription-coupled  repair.  In  addition,  these  cells  are 
completely or greatly deficient in  the  repair of UV-dam- 
aged DNA. 
The XP-B  gene encodes  a  3'  --> 5'  helicase, XP-D  a 
5' --> 3' helicase. They are components of the transcription 
factor TFIIH and together are thought to form a bidirec- 
tional helicase  (28).  This helicase appears essential for the 
local  opening  of the  DNA helix  to  allow loading  of the 
RNA polymerase and initiation of transcription  (28).  This 
function is presumably weakened in the XP-B and XP-D 
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patients with CS, but must still  proceed sufficiently to al- 
low overall transcription to occur. Given our findings here, 
these mutant proteins must also permit the loading of the 
postulated mutator factor and sufficient transcription to al- 
low somatic mutation to proceed. XP-B and XP-D are also 
required for NER by opening the double helix around the 
lesion  (8),  again acting as components of TFIIH. It is not 
clear how their presence in  the  repair complex relates to 
their  presence  in  the  transcription  complex  (27).  In  any 
case, in the XP-B and XP-D patients whose cells we stud- 
ied, NER is essentially absent. Finding somatically mutated 
Ig genes would suggest that classical  NER is not required 
for  somatic  mutation,  unless  of course  mutation-specific 
helicases  are  produced  and  can  interact  with  the  other 
components of NER.  In another study,  two siblings with 
XP-D without Cockayne syndrome were also found to ex- hibit normal levels of somatic hypermutation (14). 
CS-A may be a transcription/repair-coupling factor (29). 
It interacts with the transcription factor TFIIH and is essen- 
tial for NElL of transcribed genes (30).  Therefore, it was a 
prime  candidate for a gene required for somatic mutation, 
if that  involves  NER  coupled  to transcription.  However, 
CS-A does not seem to be essential for somatic mutation, 
suggesting  once  more  that  NElL  is  not  the  basis  for this 
process. 
The XP-V gene has not been cloned,  but XP-V is in- 
volved in the  repair  of DNA  damage  that interferes  with 
DNA rephcation (postreplication repair) and perhaps NElL 
(8).  These  patients  are  classified  as  XP,  because  of their 
photosensitivity  and modest  decrease  in the  repair  of UV 
damage.  The  patient  whose  cells  we  studied  had  clinical 
symptoms of CS.  However,  somatic mutation  of Ig genes 
appears normal. 
From these data it appears likely that NER  is not essen- 
tial  for  somatic  hypermutation,  because  defects  in  four 
genes  required  for  NER  allow  normal  levels  of somatic 
mutation.  Furthermore,  in the analysis of a mouse mutant 
in  the  NElL  gene  XP-C,  normal  somatic  hypermutation 
was also found (31). A number of other genes known to be 
required for NER  (XP-A, XP-E, XP-F, XP-G, and CS-B) 
have not been tested by us. We assume that their deletion 
would not  eliminate  somatic  mutation  either,  because  all 
the  XP  and  CS  proteins  appear  to  be  needed  for  NER. 
Thus,  if the  transcription  coupled repair  model is  correct 
(7), another type of repair mechanism, perhaps a novel one, 
may be involved. These possibilities  are currently being tested. 
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